Unfortunately, because this is a supplement we're not allowed to make medical claims regarding its use as a treatment or cure. However, this is the exact reason we began using this product on our own pets. (Our founding pets were diagnosed with cancer; one was 16 and the other was 8.) We used phytocannabinoidas palliative care for appetite and pain management.
Marijuana use is most common amongst IBD patients with a history of abdominal surgery and worse symptom scores.285 Cannabinoids have been shown to inhibit intestinal secretion and may help with diarrheal symptoms.268,269,286 Severe IBD patients also suffer with a loss of appetite, and cannabis is known to enhance appetite.287 Notably, cannabis is not without side effects. Almost a third of patients reported paranoia and anxiety,285 and there are known long-term mental health consequences of chronic cannabis use.288 Palpitations and cardiac effects have been reported in cannabis users.289
Given the uncertainties and handicaps associated with hemp, it is fortunate that there are compensating factors. As noted, as a crop hemp offers some real environmental advantages, particularly with regard to the limited needs for herbicides and pesticides. Hemp is therefore pre-adapted to organic agriculture, and accordingly to the growing market for products associated with environmentally-friendly, sustainable production. Hemp products are an advertiser’s dream, lending themselves to hyperbole (“healthiest salad oil in the world,” “toughest jeans on the market”). While the narcotics image of C. sativa is often disadvantageous, advertisers who choose to play up this association do so knowing that it will attract a segment of the consuming population. In general, the novelty of hemp means that many consumers are willing to pay a premium price. It might also be said that those who have entered the hemp industry have tended to be very highly motivated, resourceful, and industrious, qualities that have been needed in the face of rather formidable obstacles to progress.
The AKC Canine Health Foundation (CHF) is currently sponsoring a study, through the Colorado State University’s College of Veterinary Medicine and Biomedical Sciences, that will evaluate the use of CBD in treatment-resistant epileptic dogs. The CHF hopes that this will be the first study to gain scientific data on the use of CBD in dogs with this condition.